BEGIN:VCALENDAR
PRODID:-//Columba Systems Ltd//NONSGML CPNG/SpringViewer/ICal Output/3.3-
 M3//EN
VERSION:2.0
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
DTSTAMP:20231122T075736Z
DTSTART:20231118T153000Z
DTEND:20231118T170000Z
SUMMARY:Annual lecture for Professor Peter Noyce CBE- Professor Dyfrig Hu
 ghes (Bangor University)
UID:{http://www.columbasystems.com/customers/uom/gpp/eventid/}y2cb-lp9h27
 lq-za8xls
DESCRIPTION:We are delighted to be holding the seventh annual lecture for
  Professor Peter Noyce CBE on Monday 18 December 2023 at 3.30pm and we w
 ould like to invite you to join us at this important event. \n\nProfesso
 r Dyfrig Hughes\, Bangor University\, has kindly agreed to deliver the l
 ecture this year entitled . ‘Medicines optimisation research: Developing
  the evidence and informing policy and practice’.\n\nThe lecture will be
  held in Lecture theatre 5 in the Stopford Building\, University of Manc
 hester and remotely via Zoom. \n\nIf you would like to attend\, could yo
 u please [https://forms.office.com/e/iVMhiyxM8E register by completing t
 his online form]\n \n\n\nAbstract:			\nMedicines are the second highest 
 cost to the NHS after staff. There is significant potential\, therefore\
 , for inappropriate prescribing or for sub-optimal use of medicines to i
 mpose a large opportunity cost. Medicines optimisation is about achievin
 g effective\, safe and cost-effective use of medicines in order to impro
 ve health outcomes. This involves\, amongst other interventions and appr
 oaches: personalising therapy\, reducing inappropriate polypharmacy\, im
 proving medication adherence\, and prioritising high-value medicines. Th
 is lecture reflects on over 25 years of research focusing on the economi
 cs of medicines\, pharmacogenetic tests\, medication adherence and in de
 veloping pharmaceutical policies aimed ultimately to maximise population
  health.\n\n\nBiography:	Professor Dyfrig Hughes \nDyfrig Hughes is Prof
 essor of Pharmacoeconomics at the North Wales Medical School\, Bangor Un
 iversity where he is also co-director of the Centre for Health Economics
  and Medicines Evaluation and Director for Research\, Impact and Engagem
 ent. Coming from a background in pharmacy and pharmacology\, Dyfrig's re
 search focuses primarily on pharmaceutical economics\, policy and prescr
 ibing. He has led and contributed to research totalling £90m in value\, 
 resulting in over 240 publications. \n\nDyfrig has national roles suppor
 ting the NHS\, including being vice-chair of the All Wales Medicines Str
 ategy Group\, chair of the National Pharmacogenomics Group (for Wales)\,
  and chair of the Pharmacogenomics Test Evaluation Working Group (NHSE).
  He is also member of the NHSE Genomics Informed Medicines Optimisation 
 Group\, and has advisory roles relating to the MHRA’s Yellow Card Bioban
 k project\, and the EMA’s Committee for Orphan Medicinal Products. Dyfri
 g has been a Health and Care Research Wales Senior Research Leader since
  2016\, and was inaugural president of the International Society for Med
 ication Adherence. He is also honorary professor at the Department of Ph
 armacology and Therapeutics\, University of Liverpool\, and visiting pro
 fessor at the Faculty of Pharmacy\, University of Turin.\n\n \n\n\n\n \n
 \n
STATUS:TENTATIVE
TRANSP:TRANSPARENT
CLASS:PUBLIC
LOCATION:Lecture theatre 5\, Stopford Building\, Manchester
END:VEVENT
END:VCALENDAR